POON CHRISTINE A
SEC CIK 1189014 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | Dir | 4,753 | — | — | 2 | 2025-05-22 | 2026-05-21 |
| PRU | Prudential Financial | Dir | 13.3K | — | — | 10 | 2022-05-10 | 2026-05-12 |
| REGN | Regeneron Pharmaceuticals | Dir | 5,219 | — | $46.45M | 16 | 2021-08-27 | 2026-01-02 |
| SHW | Sherwin-Williams | Dir | 2,573 | — | — | 20 | 2021-07-02 | 2025-04-04 |
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
| 19 | POON CHRISTINE A | Dir | — | — |
Transactions 48
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 19:22 | 2026-05-21 | NBIX | NEUROCRINE BIOSCIENCES INC | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +3,318 | 4,753 | +231% | $0 |
| D | 2026-05-14 12:47 | 2026-05-12 | PRU | Prudential Financial | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,765 | 13.3K | +15% | $0 |
| D | 2026-05-14 12:47 | 2026-05-12 | PRU | Prudential Financial | POON CHRISTINE A | Dir | D - Sale to Iss | $102.58 | -1,765 | 11.6K | -13% | -$181.1K |
| D | 2026-01-06 | 2026-01-02 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | A - Grant | $0.00 | +155 | 5,219 | +3% | $0 |
| DM | 2025-10-31 | 2025-10-29 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | S - Sale+OE | $654.27 | -6,500 | 3,552 | -65% | -$4.25M |
| DM | 2025-10-31 | 2025-10-29+ | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | M - OptEx | $520.01 | +9,212 | 8,852 | New | +$4.79M |
| D | 2025-05-22 | 2025-05-22 | NBIX | NEUROCRINE BIOSCIENCES INC | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,435 | 1,435 | New | $0 |
| D | 2025-05-15 | 2025-05-13 | PRU | Prudential Financial | POON CHRISTINE A | Dir | D - Sale to Iss | $107.40 | -1,321 | 11.6K | -10% | -$141.9K |
| D | 2025-05-15 | 2025-05-13 | PRU | Prudential Financial | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,321 | 12.9K | +11% | $0 |
| I | 2025-04-07 | 2025-04-04 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $338.25 | +4.11 | 2,573 | +0.2% | +$1,390 |
| 2025-02-20 | 2025-02-18 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $0.00 | +517 | 12.4K | +4% | $0 | |
| I | 2025-01-07 | 2025-01-03 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $335.00 | +25.19 | 2,563 | +1.0% | +$8,439 |
| D | 2025-01-06 | 2024-12-20 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | W - Inherited | $0.00 | +14 | 2,186 | +0.6% | $0 |
| D | 2025-01-06 | 2025-01-02 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | A - Grant | $0.00 | +166 | 2,352 | +8% | $0 |
| I | 2024-10-08 | 2024-10-04 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $372.47 | +22.65 | 2,534 | +0.9% | +$8,436 |
| DM | 2024-08-19 | 2024-08-15 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | S - Sale+OE | $1,158.17 | -10.8K | 2,506 | -81% | -$12.55M |
| D | 2024-08-19 | 2024-08-15 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | M - OptEx | $413.33 | +10.8K | 13.0K | +499% | +$4.48M |
| I | 2024-07-09 | 2024-07-05 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $295.50 | +28.55 | 2,506 | +1% | +$8,437 |
| D | 2024-05-13 | 2024-05-09 | PRU | Prudential Financial | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,935 | 13.5K | +17% | $0 |
| D | 2024-05-13 | 2024-05-09 | PRU | Prudential Financial | POON CHRISTINE A | Dir | D - Sale to Iss | $117.95 | -1,935 | 11.6K | -14% | -$228.2K |
| I | 2024-04-09 | 2024-04-05 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $331.56 | +25.45 | 2,471 | +1% | +$8,438 |
| 2024-02-15 | 2024-02-13 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $0.00 | +594 | 11.9K | +5% | $0 | |
| I | 2024-01-09 | 2024-01-05 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $296.96 | +28.41 | 2,441 | +1% | +$8,437 |
| D | 2024-01-04 | 2024-01-02 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | A - Grant | $0.00 | +135 | 2,172 | +7% | $0 |
| I | 2023-10-10 | 2023-10-06 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $253.15 | +32.10 | 2,407 | +1% | +$8,126 |
| DM | 2023-08-25 | 2023-08-23 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | S - Sale+OE | $839.97 | -12.3K | 8,987 | -58% | -$10.31M |
| D | 2023-08-25 | 2023-08-23 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | M - OptEx | $273.67 | +12.3K | 14.3K | +603% | +$3.36M |
| I | 2023-07-10 | 2023-07-07 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $257.00 | +31.62 | 2,370 | +1% | +$8,126 |
| D | 2023-05-11 | 2023-05-09 | PRU | Prudential Financial | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,517 | 13.1K | +13% | $0 |
| D | 2023-05-11 | 2023-05-09 | PRU | Prudential Financial | POON CHRISTINE A | Dir | D - Sale to Iss | $81.50 | -1,517 | 11.6K | -12% | -$123.6K |
| I | 2023-04-12 | 2023-04-10 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $223.68 | +36.32 | 2,333 | +2% | +$8,124 |
| 2023-02-16 | 2023-02-14 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $0.00 | +711 | 11.3K | +7% | $0 | |
| I | 2023-01-10 | 2023-01-06 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $232.66 | +34.92 | 2,290 | +2% | +$8,124 |
| D | 2023-01-05 | 2023-01-03 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | A - Grant | $0.00 | +165 | 2,037 | +9% | $0 |
| I | 2022-10-11 | 2022-10-07 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $209.43 | +38.80 | 2,250 | +2% | +$8,126 |
| DM | 2022-08-11 | 2022-08-09 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | S - Sale+OE | $620.91 | -15.0K | 1,872 | -89% | -$9.31M |
| D | 2022-08-11 | 2022-08-09 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | M - OptEx | $177.82 | +15.0K | 16.9K | +801% | +$2.67M |
| I | 2022-07-12 | 2022-07-08 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $237.91 | +34.15 | 2,205 | +2% | +$8,125 |
| D | 2022-05-12 | 2022-05-10 | PRU | Prudential Financial | POON CHRISTINE A | Dir | M - OptEx | $0.00 | +1,494 | 13.1K | +13% | $0 |
| D | 2022-05-12 | 2022-05-10 | PRU | Prudential Financial | POON CHRISTINE A | Dir | D - Sale to Iss | $104.25 | -1,494 | 11.6K | -11% | -$155.7K |
| I | 2022-04-12 | 2022-04-08 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $264.59 | +30.71 | 2,167 | +1% | +$8,126 |
| 2022-02-17 | 2022-02-15 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $0.00 | +529 | 10.6K | +5% | $0 | |
| I | 2022-01-11 | 2022-01-07 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $327.94 | +24.78 | 2,131 | +1% | +$8,126 |
| D | 2022-01-05 | 2022-01-03 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | A - Grant | $0.00 | +191 | 1,872 | +11% | $0 |
| I | 2021-10-13 | 2021-10-08 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $291.45 | +26.81 | 2,103 | +1% | +$7,814 |
| D | 2021-08-31 | 2021-08-27 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | M - OptEx | $57.11 | +15.0K | 16.7K | +892% | +$856.6K |
| DM | 2021-08-31 | 2021-08-27 | REGN | Regeneron Pharmaceuticals | POON CHRISTINE A | Dir | S - Sale+OE | $668.09 | -15.0K | 13.6K | -52% | -$10.02M |
| I | 2021-07-07 | 2021-07-02 | SHW | Sherwin-Williams | POON CHRISTINE A | Dir | A - Grant | $274.96 | +28.41 | 2,072 | +1% | +$7,812 |
Purchase Sale Sale after option exercise All abbreviations